ASH Review: Current Updates in Hematologic Diseases
Saturday, March 7, 2015
Kansas City Marriott Country Club Plaza, Kansas City, Mo.
Suman Kambhampati, M.D.
Clinical Associate Professor, University of Kansas Medical Center, Kansas City, Mo.
Hematologic malignancies continue to be a major cause of morbidity and mortality. Major strides are being made in the management of these diseases. The American Society of Hematology (ASH) Annual Meeting serves as an avenue to discuss the most recent breakthroughs in the treatment of these malignancies. This review will discuss highlights from the 2014 ASH Meeting. It will also provide opportunities for local physicians and medical health workers to discuss these advances with renowned experts in the field.
This symposium is designed for physicians, nurses and health care providers working in various roles in the fields of hematology and oncology, and providers of care or services for patients with hematologic conditions.
At the completion of this conference, participants should be able to:
- discuss and debate emerging data and recent advances relating to the treatment of patients with hematologic malignancies and diseases and integrate key findings into clinical practice.
Financial contributions and supporters of this program will be acknowledged in print at the symposium.
Commercial vendors are invited to exhibit at this meeting. Limited exhibit space will be available. Call Julie Darrington at 913-588-4581 or e-mail email@example.com for an application or more information.